Secretome proteins as candidate biomarkers for aggressive thyroid carcinomas-Reference-Cited by-同舟云学术

Secretome proteins as candidate biomarkers for aggressive thyroid carcinomas

Published:2013-03 Issue:5 Volume:13 Page:771-787
ISSN:1615-9853
Container-title:PROTEOMICS
language:en
Short-container-title:Proteomics

Author:

Chaker Seham¹²,Kashat Lawrence¹,Voisin Sebastien³,Kaur Jatinder¹,Kak Ipshita¹,MacMillan Christina⁴,Ozcelik Hilmi⁵,Michael Siu K. W.³,Ralhan Ranju¹²⁴⁶⁷,Walfish Paul G.¹²⁴⁶⁸

Affiliation:

1. Alex and Simona Shnaider Laboratory in Molecular Oncology; Samuel Lunenfeld Research Institute; Mount Sinai Hospital; Toronto ON Canada

2. Institute of Medical Science; University of Toronto; Toronto ON Canada

3. Department of Chemistry and Centre for Research in Mass Spectrometry; York University; Toronto ON Canada

4. Department of Pathology & Laboratory Medicine; Mount Sinai Hospital; Toronto ON Canada

5. Samuel Lunenfeld Research Institute; Mount Sinai Hospital L6-303; Toronto ON Canada

6. Joseph and Mildred Sonshine Family Centre for Head and Neck Diseases; Department of Otolaryngology-Head and Neck Surgery Program; Mount Sinai Hospital; Toronto ON Canada

7. Department of Otolaryngology-Head and Neck Surgery; University of Toronto; Toronto ON Canada

8. Department of Medicine; Endocrine Division; Mount Sinai Hospital and University of Toronto Medical School; Toronto ON Canada. Department of Otolaryngology-Head and Neck Surgery; University of Toronto; Toronto ON Canada

Funder

Mount Sinai Foundation of Toronto

Da Vinci Gala Fundraiser

Alex and Simona Shnaider Chair in Thyroid Cancer

Canadian Institutes of Health Research

Advanced Cancer Diagnostics

George Knudson Oakdale Golf Fund Raiser

Mount Sinai Hospital Department of Medicine Research Fund

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pmic.201200356/fullpdf

Reference93 articles.

1. Thyroid cancer epidemiology and prognostic variables;Sipos;Clin. Oncol. (R. Coll. Radiol.),2010

2. Standard and emerging therapies for metastatic differentiated thyroid cancer;O'Neill;Oncologist,2010

3. Update on the diagnosis and therapy of distant metastases of differentiated thyroid carcinoma;Zanotti-Fregonara;Minerva Endocrinol.,2008

4. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy;Durante;J. Clin. Endocrinol. Metab.,2006

5. Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma;Pelizzo;Minerva Endocrinol.,2008

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers;Cancers;2021-10-15

2. Proteomic Analysis of Zn Depletion/Repletion in the Hormone-Secreting Thyroid Follicular Cell Line FRTL-5;Nutrients;2018-12-14

3. A translational view of cells' secretome analysis - from untargeted proteomics to potential circulating biomarkers;Biochimie;2018-12

4. Proteomic approaches to decipher cancer cell secretome;Seminars in Cell & Developmental Biology;2018-06

5. Axl inhibitors as novel cancer therapeutic agents;Life Sciences;2018-04